Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
A new generation of experimental HIV vaccines is showing unprecedented results in preclinical studies. Scientists are now moving closer to triggering broadly neutralizing antibodies against HIV. After decades of research, the race for an effective HIV vaccine is entering a new chapter. Science is fighting back.